{"result": "(\"entity\"<|>CASANUEVA FF<|>PERSON<|>Casanueva FF is an author who contributed to the study of prolactin disorders, focusing on epidemiology and causes excluding prolactin-secreting pituitary tumors.)\n##\n(\"entity\"<|>TRITOS NA<|>PERSON<|>Tritos NA is an editor and contributor to the book on prolactin disorders, involved in the clinical management of such conditions.)\n##\n(\"entity\"<|>KLIBANSKY A<|>PERSON<|>Klibansky A is an editor and contributor to the book on prolactin disorders, focusing on the clinical aspects of hormone management.)\n##\n(\"entity\"<|>SPRINGER NATURE SWITZERLAND AG<|>ORGANIZATION<|>Springer Nature Switzerland AG is the publishing company that published the book on prolactin disorders.)\n##\n(\"entity\"<|>HUMANA PRESS<|>ORGANIZATION<|>Humana Press is a publishing imprint under Springer Nature that focuses on medical and scientific literature.)\n##\n(\"entity\"<|>PROLACTIN DISORDERS<|>EVENT<|>Prolactin disorders refer to medical conditions related to abnormal levels of prolactin, which can affect various bodily functions and require clinical management.)\n##\n(\"entity\"<|>HIPOPITUITARISMO<|>EVENT<|>Hipopituitarismo is a medical condition characterized by the underproduction of hormones by the pituitary gland, often requiring hormone replacement therapy.)\n##\n(\"entity\"<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Manual de Endocrinología y Nutrición is a comprehensive guide on endocrinology and nutrition published by the Sociedad Española de Endocrinología y Nutrición.)\n##\n(\"relationship\"<|>CASANUEVA FF<|>TRITOS NA<|>Casanueva FF and Tritos NA are both contributors to the book on prolactin disorders, indicating a collaborative relationship<|>7)\n##\n(\"relationship\"<|>CASANUEVA FF<|>KLIBANSKY A<|>Casanueva FF and Klibansky A are both contributors to the book on prolactin disorders, indicating a collaborative relationship<|>7)\n##\n(\"relationship\"<|>TRITOS NA<|>KLIBANSKY A<|>Tritos NA and Klibansky A are both contributors to the book on prolactin disorders, indicating a collaborative relationship<|>7)\n##\n(\"relationship\"<|>SPRINGER NATURE SWITZERLAND AG<|>HUMANA PRESS<|>Springer Nature Switzerland AG is the parent company of Humana Press, indicating a corporate relationship<|>8)\n##\n(\"relationship\"<|>PROLACTIN DISORDERS<|>HIPOPITUITARISMO<|>Prolactin disorders can be a part of the broader category of conditions treated in the context of hypopituitarism, indicating a medical relationship<|>6)\n##\n(\"relationship\"<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>HIPOPITUITARISMO<|>The Manual de Endocrinología y Nutrición provides information on hypopituitarism, indicating a reference relationship<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Casanueva FF. Prolactin excess and deficiency: Epidemiology, causes (excluding prolactin-secreting pituitary tumors). En: Tritos NA, Klibansky A. Prolactin disorders. From basic science to clinical management. 1.ª ed. Springer Nature Switzerland AG; Humana Press; 2019.\n\n## 12. Indique la afirmación incorrecta respecto al tratamiento sustitutivo del hipopituitarismo adquirido en adultos:\n\nA. No debe iniciarse tratamiento con tiroxina hasta no se haya evaluado la función adrenal.\nB. En adulto joven se debe realizar sustitución con testosterona o bien con estrógenos y progestágenos.\nC. Los niveles de ACTH durante el tratamiento son de utilidad para el ajuste de dosis de glucocorticoides.\nD. La sustitución con glucocorticoides puede desenmascarar la presencia de una diabetes insípida previamente inadvertida.\n\n### COMENTARIO\n\nEl tratamiento sustitutivo del hipopituitarismo consiste en la reposición de las hormonas de los órganos diana (respuesta B), salvo en el caso del déficit de GH o en el déficit de gonadotropinas cuando se desea fertilidad, ya que precisa sustitución con las hormonas hipofisarias.\n\nCuando hay un déficit combinado, el orden de sustitución terapéutica es esencial. El primer eje que se ha de sustituir es el adrenocortical, seguido del tiroideo y posteriormente el gonadal y el somatotropo. Cuando existe un déficit de TSH no debe iniciarse el tratamiento hasta haber reevaluado la reserva adrenal, puesto que, si existiese hipotiroidismo e insuficiencia suprarrenal coexistentes, el tratamiento del hipotiroidismo primero aumentaría el aclaramiento de la pequeña cantidad de cortisol disponible, aumentando la gravedad de la deficiencia de cortisol (respuesta A).\n\nRespecto al déficit de ACTH, el ajuste del tratamiento se realiza a través de datos clínicos (bienestar, tensión arterial en decúbito y en supino, peso, iones, glucosa y lípidos), ya que la ACTH va a seguir baja (no se sustituye, se proporciona la hormona diana). Deben emplearse las dosis mínimas necesarias de glucocorticoides que controlen la clínica del paciente. La presencia de síntomas de hipocortisolismo (cansancio, náuseas, pérdida de peso, etc.) indicaría la necesidad de aumentar la dosis, mientras que el aumento de peso, los edemas o la hipertensión arterial reflejaría la necesidad de reducir la dosis (respuesta C falsa).\n\nLa insuficiencia adrenal no tratada puede enmascarar la presencia de diabetes insípida. Por este motivo, es importante estar atentos ante la posibilidad de desarrollar una diabetes insípida tras el inicio de la sustitución glucocorticoidea. Del mismo modo, pacientes con mejoría de su diabetes insípida (y que no estaban diagnosticados de insuficiencia adrenal), deben evaluar de nuevo su eje ACTH-cortisol para descartar un nuevo déficit.\n\nReferencias:\n- López-Fernández J, Oliva García JG, Pérez Luis JM. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015. Capítulo 17. Hipopituitarismo; [citado 29.4.2019]. Disponible en: https://manual.seen.es/article?id=55114b66-489c-4c70-8a67-2bcdac18103c.\n---\n# HIPÓFISIS\n\n## 13. ¿Cuál es el déficit hormonal más frecuente tras traumatismo craneal severo?\n\nA. Déficit de GH (disminución de respuesta a test de estímulo).\nB. Hipotiroidismo hipofisario.\nC. Hipogonadismo hipofisario.\nD. Hipocortisolismo hipofisario.\n\n### COMENTARIO\n\nLos traumatismos craneales, especialmente aquellos con suficiente gravedad para fracturar la base del cráneo, pueden causar déficit de hormonas hipotálamo-hipofisarias. La probabilidad de desarrollar alteraciones hormonales se relaciona directamente con la gravedad del trauma. La aparición de deficiencias adenohipofisarias suele ser aguda, y es mucho menos frecuente su aparición tardía, a partir de los 3-12 meses tras el trauma.\n\n- El déficit de GH, evaluado mediante test de estímulo, es el más frecuente en contexto de un trauma craneal, mientras que la frecuencia de aparición de hipoadrenalismo, hipotiroidismo e hipogonadismo es menor.\n\nLas alteraciones en la secreción de vasopresina son comunes en la fase aguda, en forma de diabetes insípida o SIADH transitorios, pero pocos casos persisten posteriormente.\n\nReferencias:\n- Snyder PJ. Causes of hypopituitarism. En: Cooper DS, Martin KA, eds. UpToDate. Waltham, MA: UpToDate Inc.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}